A bankruptcy filing Sunday by 23andMe, a genetic testing and biotechnology company, is shining light on what could happen to ...
Kezar Life Sciences (KZR) stock falls as the company announces Q4 results with mid-stage trial data for its lead asset ...
The company saw its DNA data as an engine that would revolutionize drug discovery and medical care, but it never found a ...
The medtech AI startup can’t properly staff up in only its hometown, according to cofounder Shiv Rao. Local leaders say it’s ...
Alumis shares rose after the company signed a licensing agreement, worth $40 million in the short-term, with Tokyo-based Kaken Pharmaceutical. The stock climbed 17.9% to $4.45 on Tuesday, recovering ...
As part of cost-cutting efforts, Alector will let go of about 25 people during the third quarter of 2025 as it focuses on ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Alexandria Real Estate Equities has unveiled plans for a mega-project in the San Francisco Peninsula that will transform an ...
The South San Francisco-based company, which pioneered at-home genetic testing, holds a trove of sensitive genetic data on ...
The Southern Maryland Chronicle on MSN23h
Genetics Firm 23andMe Files Bankruptcy, Seeks Buyer in Missouri CourtOn March 23, 2025, 23andMe Holding Co. (Nasdaq: ME), a prominent genetics and biotechnology firm, announced it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback